CLINICAL EFFECTIVENESS AND INFECTION RATE IN RHEUMATOID ARTHRITIS PATIENTS SWITCHED FROM ANTI-TNF AGENTS TO ABATACEPT

被引：0
|
作者：
Pietrosanti, M. [1 ]
Di Rosa, R. [1 ]
Salemi, S. [1 ]
Markovic, M. [1 ]
Carusi, V. [1 ]
Biondo, M. I. [1 ]
Catoni, M. [1 ]
Lagana, B. [1 ]
Sorgi, M. L. [1 ]
D'Amelio, R. [1 ]
机构：
[1] Univ Roma La Sapienza, Fac Med & Psicol, Clin Immunol & Rheumatol Div, I-00185 Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：888 / 888
页数：1
相关论文
共 50 条
  • [1] Comparative Effectiveness of Abatacept Versus Subsequent Anti-TNF Agents Among Rheumatoid Arthritis Patients with Previous Anti-TNF Exposure.
    Harrold, Leslie R.
    Reed, George
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc
    Onofrei, Alina U.
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1019 - S1019
  • [2] Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
    Rosalia Martínez-Pérez
    Julia Uceda
    Mario León
    Sergio Rodríguez
    Alejandro Muñoz
    Francisco Gallo
    Maria Luisa Velloso
    Jose Luis Marenco
    [J]. Journal of Translational Medicine, 9 (Suppl 2)
  • [3] Anti-TNF agents for rheumatoid arthritis
    Seymour, HE
    Worsley, A
    Smith, JM
    Thomas, SHL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 201 - 208
  • [4] Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
    Johnston, Stephen S.
    Turpcu, Adam
    Shi, Nianwen
    Fowler, Robert
    Chu, Bong-Chul
    Alexander, Kimberly
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 39 - 47
  • [5] Use of Rituximab or Abatacept after Anti-TNF Discontinuation in Patients with Severe Rheumatoid Arthritis
    Barnabe, C.
    Hazlewood, G.
    Barr, S. G.
    Martin, L.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2564 - 2564
  • [6] Clinical effectiveness of anti-TNF, non-anti-TNF and tofacitinib in the treatment of rheumatoid arthritis
    Oliveira, Gerusa
    Morgado, Marina
    Brandao, Natalia
    Barreto, Jessica
    Acurcio, Francisco A.
    Guerra Junior, Augusto
    Alvares-Teodoro, Juliana
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 170 - 170
  • [7] Remission for rheumatoid arthritis patients on anti-TNF in clinical practice
    Murphy, Kevin
    Butt, Sayqa
    Gadsby, Kate
    Deighton, Chris
    [J]. RHEUMATOLOGY, 2008, 47 : II40 - II40
  • [8] Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
    Fragoulakis, Vasilis
    Vitsou, Elli
    Hernandez, Ana Cristina
    Maniadakis, Nikolaos
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 85 - 93
  • [9] Maintenance of anti-TNF agents in rheumatoid arthritis patients in daily practice
    Schaeverbeke, T
    Dumoulin, C
    Richez, C
    Mehsen, N
    Bentaberry, F
    Monnier, A
    Dehais, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 301 - 301
  • [10] Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis
    Manfredi, Angelo A.
    Baldini, Mattia
    Camera, Marina
    Baldissera, Elena
    Brambilla, Marta
    Peretti, Giuseppe
    Maseri, Attilio
    Rovere-Querini, Patrizia
    Tremoli, Elena
    Sabbadini, Maria Grazia
    Maugeri, Norma
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (08) : 1511 - 1520
12345